Welcome to our dedicated page for Bon Natural Life SEC filings (Ticker: BON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bon Natural Life Limited filings document a Cayman Islands foreign private issuer operating through a bio-ingredient business for the natural, health, personal care, functional food, cosmetic, and pharmaceutical industries. The company's Form 6-K reports disclose interim operating results, product commercialization activity, and material agreements involving its subsidiary Xi'an App-Chem Bio (Tech) Co., Ltd.
The filing record covers sales cooperation agreements for Apple Series products, tea pigment digestive health products, and natural weight-management products, including disclosures on research and development, manufacturing, quality control, and distribution rights. Other reports describe framework cooperation for AI-driven natural-ingredient bio-manufacturing, executive officer transitions, and Nasdaq continued-listing compliance matters.
Bon Natural Life Ltd director Zhixiang Gao has filed a Form 3 ownership report for the company’s common stock. The data provided shows no reported purchases, sales, gifts, or option exercises in this filing, and no derivative positions are listed.
Bon Natural Life Ltd director Chen Jing Veronica filed an initial Form 3, which is a required disclosure of insider status and beneficial ownership. This filing reports no stock transactions, and the data provided does not list any derivative positions, making it a routine compliance update.
Bon Natural Life Ltd director and Chief Executive Officer Hu Yongwei filed an initial insider ownership report. The filing shows direct holdings of 2,004,427 Class B ordinary shares and 80,177 Class A ordinary shares. The Class B shares are convertible, at Hu’s discretion, into an aggregate of 80,177 Class A shares under applicable terms.
Bon Natural Life Ltd Chief Operating Officer Xue Yingchun filed an initial ownership report showing indirect holdings of the company’s Class A Ordinary Shares. The filing reports beneficial ownership of 120 Class A Ordinary Shares held through Lavender Oil Limited, reflecting Xue’s proportional ownership interest in that entity.
Bon Natural Life Ltd disclosed that Ma Xin, the company’s Chief Financial Officer, has filed an initial Form 3 as a reporting person. This filing establishes Ma Xin’s status as an officer subject to insider reporting rules but does not report any specific transactions or derivative positions.
Bon Natural Life Ltd filed an initial ownership report for Chief Marketing Officer Wenjuan Chen. The filing shows indirect beneficial ownership of 80 Class A Ordinary Shares, which are held directly by Lavender Oil Limited, an entity in which Chen holds a proportional ownership interest.
Bon Natural Life Ltd director and Chief Technology Officer liu jing filed an initial ownership report showing a significant equity stake. A footnote states that liu jing holds 2,004,427 Class B ordinary shares, which are convertible, at the reporting person's discretion, into an aggregate of 80,177 Class A ordinary shares, subject to applicable terms and conditions. The filing also reports direct ownership of 1,496 Class A ordinary shares, giving investors a view of the CTO’s aligned interest through both high-vote Class B stock and its Class A equivalent.
Bon Natural Life Ltd director Gao Jianjun has filed an initial Form 3, which is the first statement of beneficial ownership as a company insider. The data provided shows no reported purchases, sales, gifts, or derivative exercises, and no current derivative positions listed.
Bon Natural Life Limited reported a leadership change in its technology function. On March 12, 2026, Chief Technology Officer and Chief Scientist Jianli Liu resigned from all positions with immediate effect, with no known disagreements related to the company’s operations, policies or practices.
Effective March 16, 2026, the company appointed Jing Liu, a current director and the wife of controller Hu Yongwei, as Chief Technology Officer. She is a long-time lecturer at Xi’an University of Science and Technology with research in supramolecular chemistry, chemical processes and new energy technologies. Under an employment agreement effective March 16, 2026, she will receive a monthly salary of approximately $1,000.
Bon Natural Life Limited reported that its subsidiary Xi’an App-Chem Bio-Tech Co., Ltd. signed a three-year Framework Cooperation Agreement with Shaanxi Chang’an Pilot Life Science Industry Innovation Center to build an integrated innovation chain from basic research to industrial application.
The partners will co-establish the “BON & Pilot Natural Ingredients and Biomanufacturing Joint Laboratory,” focusing on AI-driven bio-manufacturing of natural active ingredients for functional foods and personal care products, plus a future engineering center for process development and pilot-scale verification. The Agreement also outlines broader strategic cooperation in technology R&D, market expansion, capital partnerships, and potential M&A, and may be terminated by either party with three months’ notice.